Disclosures

In accordance with ANCC policy, presenters have indicated if they have a conflict of interest and if so, it has been resolved.

The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

In direct response to the September 2004 Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, CME Consultants, Inc. issued a conflict of interest policy dated January 2, 2005. The policy states that the disclosure of potential financial conflicts of interest within the last 12 months must be made and resolved prior to date of the CME/CE activity where commercial support grants are to be used to fund the activity. The following conflicts have been managed and resolved through CME Consultants, Inc.'s Independent Review Committee. Our intent is to assist learners in assessing the potential for bias in information that is presented during the CME/CE activity.

The faculty is also aware it is their responsibility to inform the audience if discussion of any non - FDA approved uses of pharmaceutical, medical equipment, prostheses, etc. will be included in their presentation.

Randolph P. Martin, MD

Dr. Martin will discuss Non-FDA approved uses of Coronary perfusion (contrast) in the presentation.

Neil Weissman, MD

Grant/Research Support: Acusphere, Bracco, Point, BMSL. Consultant and Investigator: Acusphere. Investigator: Bracco, Point, BMSL.

William Zoghbi, MD

Dr. Zoghbi has received an honorarium from GE, research grants from BMS, Bracco, Point Biomedical and Acusphere. Scientific advisory of Point Biomedical and will discuss Non-FDA approved uses of uses of perflutren protein-type A microspheres for injection in the presentation.